Investigation of Effect of Formulated Methylene Blue on Treatment of Squamous Cell Carcinoma Skin Cancer in Inoperable Patients and Not Suitable for Radiotherapy
Clinical trial NCT07311057 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07311057
- Sponsor
- Daryoush Hamidi Alamdari, PhD
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-20
- Primary completion
- 2026-01-20
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.